- Kidney Development, Disease and Regenerative Medicine
Peter Hohenstein did his PhD in the laboratory of Riccardo Fodde in the Leiden University Medical Center, where he worked on the development and analysis of mouse models for hereditary breast (Brca1) and intestinal (Smad4) cancer. From there he went to the lab of Nick Hastie at the MRC Human Genetics Unit in Edinburgh to work on the role of Wt1 and β-catenin in normal kidney development, Wilms’ tumours and other cancer types. He stayed there for 11 years, first as post-doc, later as Senior Investigative Scientist with responsibility of the kidney and cancer projects in the lab. In 2012 he moved with his projects and part of the lab to an independent group leader position in The Roslin Institute, University of Edinburgh. He moved back to the LUMC in April 2018 to continue his research on the genetics of early kidney development and kidney disease (especially Wilms’ tumours) and further use his expertise in the control of early kidney development and nephron progenitor cells to develop and improve kidney regenerative medicine approaches. In addition he is the head of the Transgenic Facility Leiden.
Leids Universitair Medisch Centrum
2333 ZC Leiden
Tel: +31 71 5269410
2300 RC Leiden